10:04 AM EST - Theralase Technologies Inc. : Has successfully demonstrated the ability of its lead Photo Dynamic Therapy technology to increase survival by 575% for a very aggressive form of brain cancer, known as Glioblastoma Multiforme, in a rat model. Theralase Technologies Inc.
shares V.TLT are trading up $0.035 at $0.40.
